Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice
Wei Tang,1,2,*
Yi Lu,1,2,*
Qing-Yun Tian,1,*
Yan Zhang,1
Feng-Jin Guo,1,
Guang-Yi Liu,1
Nabeel Muzaffar Syed,1
Yongjie Lai,1
Edward Alan Lin,1
Li Kong,1
Jeffrey Su,3
Fangfang Yin,4,
Ai-Hao Ding,4
Alexandra Zanin-Zhorov,5
Michael L. Dustin,5
Jian Tao,6
Joseph Craft,6
Zhinan Yin,7
Jian Q. Feng,8
Steven B. Abramson,9
Xiu-Ping Yu,2
Chuan-ju Liu1,10,
Abstract:
The growth factor progranulin (PGRN) has been implicated in embryonic development, tissue repair, tumorigenesis, and inflammation, but its receptors remain unidentified. We report that PGRN bound directly to tumor necrosis factor receptors (TNFRs) and disturbed the TNFα-TNFR interaction. PGRN-deficient mice were susceptible to collagen-induced arthritis, and administration of PGRN reversed inflammatory arthritis. Atsttrin, an engineered protein composed of three PGRN fragments, exhibited selective TNFR binding. PGRN and Atsttrin prevented inflammation in multiple arthritis mouse models and inhibited TNFα-activated intracellular signaling. Collectively, these findings demonstrate that PGRN is a ligand of TNFR, an antagonist of TNFα signaling, and plays a critical role in the pathogenesis of inflammatory arthritis in mice. They also suggest new potential therapeutic interventions for various TNFα-mediated pathologies and conditions, including rheumatoid arthritis.
1 Department of Orthopaedic Surgery, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY 10003, USA. 2 Institute of Pathogenic Biology, Shandong University School of Medicine, Jinan, Shandong 250012, China. 3 Cytovance Biologics, Oklahoma City, OK 73104, USA. 4 Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10065, USA. 5 Department of Pathology, New York University School of Medicine, New York, NY 10016, USA. 6 Section of Rheumatology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. 7 College of Life Sciences, Nankai University, Tianjin 300071, China. 8 Baylor College of Dentistry, Texas A&M Health Science Center, Dallas, TX 75246, USA. 9 Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY 10003, USA. 10 Department of Cell Biology, New York University School of Medicine, New York, NY 10016, USA.
* These authors contributed equally to this work.
Present address: Chongqing Medical University, Chongqing, 400016, China.
Present address: SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA.
To whom correspondence should be addressed. E-mail: chuanju.liu{at}med.nyu.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Hao Wu and Richard M. Siegel (22 April 2011) Science332 (6028), 427.
[DOI: 10.1126/science.1205992] |Summary »|Full Text »|PDF »
In Science Signaling
EDITORS' CHOICE
Kristen L. Mueller (26 April 2011) Sci. Signal.4 (170), ec119.
[DOI: 10.1126/scisignal.4170ec119] |Abstract »
PODCASTS
Chuan-ju Liu and Annalisa M. VanHook (26 April 2011) Sci. Signal.4 (170), pc8.
[DOI: 10.1126/scisignal.2002099] |Abstract »|Full Text »|Podcast »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Progranulin Does Not Bind Tumor Necrosis Factor (TNF) Receptors and Is Not a Direct Regulator of TNF-Dependent Signaling or Bioactivity in Immune or Neuronal Cells.
X. Chen, J. Chang, Q. Deng, J. Xu, T. A. Nguyen, L. H. Martens, B. Cenik, G. Taylor, K. F. Hudson, J. Chung, et al. (2013)
J. Neurosci.
33, 9202-9213
|Abstract »|Full Text »|PDF »
TDP-43 frontotemporal lobar degeneration and autoimmune disease.
Z. A. Miller, K. P. Rankin, N. R. Graff-Radford, L. T. Takada, V. E. Sturm, C. M. Cleveland, L. A. Criswell, P. A. Jaeger, T. Stan, K. A. Heggeli, et al. (2013)
J. Neurol. Neurosurg. Psychiatry
|Abstract »|Full Text »
Secreted Progranulin Is a Homodimer and Is Not a Component of High Density Lipoproteins (HDL).
A. D. Nguyen, T. A. Nguyen, B. Cenik, G. Yu, J. Herz, T. C. Walther, W. S. Davidson, and R. V. Farese Jr. (2013)
J. Biol. Chem.
288, 8627-8635
|Abstract »|Full Text »|PDF »
Dissociation of Frontotemporal Dementia-Related Deficits and Neuroinflammation in Progranulin Haploinsufficient Mice.
A. J. Filiano, L. H. Martens, A. H. Young, B. A. Warmus, P. Zhou, G. Diaz-Ramirez, J. Jiao, Z. Zhang, E. J. Huang, F.-B. Gao, et al. (2013)
J. Neurosci.
33, 5352-5361
|Abstract »|Full Text »|PDF »
Insights into the role of progranulin in immunity, infection, and inflammation.
The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1.
G. Frampton, Y. Ueno, M. Quinn, M. McMillin, H. Y. Pae, C. Galindo, D. Leyva-Illades, and S. DeMorrow (2012)
Am J Physiol Gastrointest Liver Physiol
303, G1202-G1211
|Abstract »|Full Text »|PDF »
Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy.
J. Todoric, A. Handisurya, T. Perkmann, B. Knapp, O. Wagner, A. Tura, G. Pacini, H. Esterbauer, and A. Kautzky-Willer (2012)
Eur. J. Endocrinol.
167, 561-567
|Abstract »|Full Text »|PDF »
Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration.
B. Cenik, C. F. Sephton, B. Kutluk Cenik, J. Herz, and G. Yu (2012)
J. Biol. Chem.
287, 32298-32306
|Abstract »|Full Text »|PDF »
The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand.
C. Richter, S. Messerschmidt, G. Holeiter, J. Tepperink, S. Osswald, A. Zappe, M. Branschadel, V. Boschert, D. A. Mann, P. Scheurich, et al. (2012)
Mol. Cell. Biol.
32, 2515-2529
|Abstract »|Full Text »|PDF »
Frontotemporal Dementia: Implications for Understanding Alzheimer Disease.
M. Goedert, B. Ghetti, and M. G. Spillantini (2012)
Cold Spring Harb Perspect Med
2, a006254
|Abstract »|Full Text »|PDF »
Tumor necrosis factor receptor 1 functions as a tumor suppressor.
F. Chang, M. R. Lacey, M. Bouljihad, K. H. z. Bentrup, and I. S. Fortgang (2012)
Am J Physiol Gastrointest Liver Physiol
302, G195-G206
|Abstract »|Full Text »|PDF »